In today’s dynamic pharmaceutical environment, the urgency to embrace powerful digital infrastructure cannot be overstated. Rising costs, shifting patient expectations, and the pressing need to enhance R&D, service models, and treatments demand a fresh approach to transformation. Altivate, in partnership with RISE with SAP, presents a groundbreaking solution designed to redefine the pharmaceutical sector. As the SAP BEST RISE Partner, our track record speaks for itself; we’ve led transformative pharma ventures with industry giants like Avalon Pharma and SPIMACO. The key is a reinvention strategy that centralizes digital technology, paving the way for future sustainable growth
Digital Core: Supporting Growth in Pharma and Medical Devices
At Altivate, we recognize the urgency pharmaceutical companies face in delving deeper into their customer insights. In this data-centric world, grasping the nuances of customer behaviours, inclinations, and trends is essential. This understanding is particularly vital for our valued midmarket clients and those within the strategic customer program. While many are already leveraging the capabilities of SAP ERP 6.0, the transformative potential of SAP S/4HANA awaits them. We have seen its impact in Pharma companies and also in medical devices companies like our client’s Gulf Medical Company. Read the case study to see how implementing SAP S/4HANA helped in reducing their TCO.
Championing Business Goals in Pharma
The overarching ambition for organizations in the Pharma sector is to compete as a robust ecosystem. This involves:
- Harnessing a digital supply chain and adopting smart factory models.
- Amplifying customer outcomes.
- Ensuring growth and margin expansion.
- Achieving unparalleled business scalability – all while gaining agility, resilience, automation, and speed.
Yet, the journey towards these goals isn’t without challenges.
Addressing Pain Points Head-On
Several significant hurdles plague pharma companies:
- A concerning lack of product transparency and traceability, which can jeopardize patient safety.
- Reliance on outdated technology, manual processes, and inadequate analytics.
- A void in transparency and real-time visibility crucial for informed decision-making.
Altivate, in tandem with SAP, offers a solution to these pain points.
Unparalleled Value Offered by RISE with SAP
With RISE with SAP, pharmaceutical companies can benefit from:
- Native integration that ensures serialization and meets compliance needs of regulatory bodies.
- Function-rich planning grounded in material characteristics and product segmentation.
- A singular, integrated platform for MRP, material ledger, and transfer pricing.
The results? Tangible business value. Companies leveraging this solution have reported:
- A staggering 45%–50% surge in turnover of warehouse goods.
- A shift to 80% paperless processes.
- Full transition of equipment to predictive maintenance.
- An impressive 15-20% uptick in sales volume.
- A commendable 33% reduction in sales expenses.
At Altivate, our mission is clear: to enable organizations to fully capitalize on their digital transformation journey. Digital transformation is more than just a buzzword—it’s reshaping growth possibilities for midsize life sciences companies. By leveraging value-added services, intelligent supply chain strategies, and next-generation, cloud-based IT systems, these organizations are not only driving organic growth but also illustrating their enhanced value to prospective partners and acquirers. With RISE with SAP, we’re providing the tools and expertise to facilitate this transformative shift. Join Altivate in this venture and let’s collaboratively pave the way for a brighter, more efficient future in the pharmaceutical sector.
